Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07082010 · ClinicalTrials.gov registry record · NA
Measurement-Based Peer Supervision App for Non-Specialist Providers
A NA study of Training of Mental Health Professionals and Training of Frontline Health Workers, sponsored by Dimagi.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT07082010: Recruiting NA study of Training of Mental Health Professionals and Training of Frontline Health Workers, sponsored by Dimagi.
NCT07082010 is a NA study of Training of Mental Health Professionals and Training of Frontline Health Workers that is actively recruiting participants, run by Dimagi. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07082010, a NA study of Training of Mental Health Professionals and Training of Frontline Health Workers, is actively recruiting participants, sponsored by Dimagi.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to enhance and evaluate the efficacy of a scalable digital solution designed to help train and support the work of non-specialist providers (NSPs), such as community health workers, to deliver therapy to individuals with anxiety and/or depression. The main questions this project aims to answer are: * Can a digital tool help NSPs feel more confident in counseling patients? * How can a digital tool be designed to optimally support the work of NSPs?
Conditions Studied
Interventions
- DEVICE MBPS App
Study Locations (1)
Texas
- Baylor Scott & White Health - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07082010 shows while recruiting
NCT07082010 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Training of Mental Health Professionals appearing as the primary indexed condition, and to 1 intervention - of which MBPS App is the first listed.
NCT07082010 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07082010 about?
NCT07082010 is a clinical study titled "Measurement-Based Peer Supervision App for Non-Specialist Providers". The goal of this project is to enhance and evaluate the efficacy of a scalable digital solution designed to help train and support the work of non-specialist providers (NSPs), such as community health workers, to deliver therapy to individuals with anxiety and/or depression. The main questions this ...
What is the current status of trial NCT07082010?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2025-05-15. Estimated completion is 2026-08.
What conditions does trial NCT07082010 study?
This clinical trial studies the following conditions: Training of Mental Health Professionals, Training of Frontline Health Workers.
What interventions are being tested in trial NCT07082010?
The interventions under investigation include: MBPS App (DEVICE).
Who is sponsoring clinical trial NCT07082010?
This trial is sponsored by Dimagi, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07082010 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07082010's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI